Methyldopa and Hydrochlorothiazide (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Methyldopa and Hydrochlorothiazide drug offered from Mylan Pharmaceuticals Inc.. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | methyldopa and hydrochlorothiazide |
| SUBSTANCE NAME: | METHYLDOPA; HYDROCHLOROTHIAZIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1986-01-23 |
| END MARKETING DATE: | 0000-00-00 |
Methyldopa and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Methyldopa and Hydrochlorothiazide from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250; 15(mg/1; mg/1) |
| START MARKETING DATE: | 1986-01-23 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-0507_939cd970-6d0d-4403-a7fa-21a2b87555df |
| PRODUCT NDC: | 0378-0507 |
| APPLICATION NUMBER: | ANDA070265 |
Other METHYLDOPA; HYDROCHLOROTHIAZIDE Pharmaceutical Manufacturers / Labelers:
